19,083 followers
Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma https://t.co/0ht9HembOq https://t.co/cM7v9KnG2N
Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma https://t.co/0ht9HembOq https://t.co/cM7v9KnG2N
New research: Phase I trial of pembrolizumab plus vemurafenib and cobimetinib in patients with metastatic melanoma: Background Preclinical and translational evidence suggest BRAF/MEK inhibitors modulate the tumor microenvironment (TME),… https://t.co/ia3Y